• Info
  • Insider Ownership

Insider Trading & Ownership of Steven M. Paul

Location
Indianapolis, IN
Summary
The estimated net worth of Steven M. Paul is at least $602K dollars as of September 15, 2025. Steven M. Paul is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $416K. Steven M. Paul is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $185K.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Steven M. Paul files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Steven M. Paul

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Director $416K Sep 12, 2025
ALNY ALNYLAM PHARMACEUTICALS, INC. Director $185K Apr 1, 2022
KRTX Karuna Therapeutics, Inc. Director $0 Mar 18, 2024
SAGE Sage Therapeutics, Inc. Director Jan 3, 2024
VYGR Voyager Therapeutics, Inc. Director Jun 3, 2021

Insider Transactions Reported by Steven M. Paul:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.